Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Pseudomonas aeruginosa bacteremia and prostatitis in a patient with cystic fibrosis.

Anand A, Tullis E, Stephenson A, Nickel JC, Leveridge MJ.

Can Urol Assoc J. 2013 Jan-Feb;7(1-2):E1-3. doi: 10.5489/cuaj.11172.

2.

The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?

Banerjee D, Stableforth D.

Drugs. 2000 Nov;60(5):1053-64. Review.

PMID:
11129122
3.

Pseudomonas aeruginosa bacteraemia in an adult with cystic fibrosis and acute appendicitis.

Gilchrist FJ, Doherty CJ, Govan JR, Webb AK, Jones AM.

J Cyst Fibros. 2011 Dec;10(6):477-8. doi: 10.1016/j.jcf.2011.06.009. Epub 2011 Jul 14.

4.

Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

Moore R, Kyd JM, Carzino R, Armstrong D, Grimwood K, Otczyk DC, Cripps AW.

Hum Vaccin Immunother. 2013 Mar;9(3):506-14. Epub 2012 Dec 18.

5.

Respiratory infections with Pseudomonas aeruginosa in children with cystic fibrosis: early detection by serology and assessment of risk factors.

West SE, Zeng L, Lee BL, Kosorok MR, Laxova A, Rock MJ, Splaingard MJ, Farrell PM.

JAMA. 2002 Jun 12;287(22):2958-67.

PMID:
12052125
6.

[Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].

Winkler U, Wingender J, Jäger KE.

Klin Wochenschr. 1985 Jun 3;63(11):490-8. German.

PMID:
3925219
9.

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2015 Nov 2;(11):CD006961. doi: 10.1002/14651858.CD006961.pub3. Review.

PMID:
26522473
10.

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.

Langton Hewer SC, Smyth AR.

Cochrane Database Syst Rev. 2014 Nov 10;(11):CD004197. doi: 10.1002/14651858.CD004197.pub4. Review.

PMID:
25383937
11.

Ciprofloxacin during upper respiratory tract infections to reduce Pseudomonas aeruginosa infection in paediatric cystic fibrosis: a pilot study.

Connett GJ, Pike KC, Legg JP, Cathie K, Dewar A, Foote K, Harris A, Faust SN.

Ther Adv Respir Dis. 2015 Dec;9(6):272-80. doi: 10.1177/1753465815601571. Epub 2015 Sep 4.

PMID:
26341118
12.

Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.

Aanæs K.

J Cyst Fibros. 2013 Sep;12 Suppl 2:S1-20. doi: 10.1016/S1569-1993(13)00150-1.

13.

Successful Use of Ceftolozane-Tazobactam to Treat a Pulmonary Exacerbation of Cystic Fibrosis Caused by Multidrug-Resistant Pseudomonas aeruginosa.

Vickery SB, McClain D, Wargo KA.

Pharmacotherapy. 2016 Oct;36(10):e154-e159. doi: 10.1002/phar.1825. Epub 2016 Sep 1.

PMID:
27522066
14.

Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis.

Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, Govan JR.

Microbiology. 2007 Jun;153(Pt 6):1852-9.

PMID:
17526842
15.

Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.

Waters V, Ratjen F.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD006961. doi: 10.1002/14651858.CD006961.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;11:CD006961.

PMID:
18646176
16.

Chronic Pseudomonas aeruginosa infection and respiratory muscle impairment in cystic fibrosis.

Dassios TG, Katelari A, Doudounakis S, Dimitriou G.

Respir Care. 2014 Mar;59(3):363-70. doi: 10.4187/respcare.02549. Epub 2013 Aug 27.

17.

Pseudomonas aeruginosa diversity in distinct paediatric patient groups.

Tramper-Stranders GA, van der Ent CK, Wolfs TF, Kimpen JL, Fleer A, Johansen U, Johansen HK, Høiby N.

Clin Microbiol Infect. 2008 Oct;14(10):935-41. doi: 10.1111/j.1469-0691.2008.02054.x. Epub 2008 Aug 26.

18.

Mouse models of chronic lung infection with Pseudomonas aeruginosa: models for the study of cystic fibrosis.

Stotland PK, Radzioch D, Stevenson MM.

Pediatr Pulmonol. 2000 Nov;30(5):413-24. Review.

PMID:
11064433
19.

Bilateral hematogenous Pseudomonas aeruginosa endophthalmitis after lung transplantation.

Dua S, Chalermskulrat W, Miller MB, Landers M, Aris RM.

Am J Transplant. 2006 Jan;6(1):219-24.

20.

Specific resistance to Pseudomonas aeruginosa infection in zebrafish is mediated by the cystic fibrosis transmembrane conductance regulator.

Phennicie RT, Sullivan MJ, Singer JT, Yoder JA, Kim CH.

Infect Immun. 2010 Nov;78(11):4542-50. doi: 10.1128/IAI.00302-10. Epub 2010 Aug 23.

Supplemental Content

Support Center